cabozantinib
Drug timelines are a Plus or Pro feature.
145 regulatory and trial events tracked for cabozantinib, covering 2013-01-16 to 2026-06-29. Get the full timeline:
Most recent: Clinical Trial Results: Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure [Phase 2]